Table 3.
Patients diagnosed with cancer (according to ICD-10 registrations in NPR) among the study population during the lung cancer patient pathway (LCPP) and within 10 days after LCPP
| Patientsa n |
|
|---|---|
| Primary cancers in the chest | |
| Cancer in lymphoid tissues (ICD-10: C81-C86)b |
157 |
| Malignant pleural mesothelioma (ICD-10: C450)b |
140 |
| Cancer in thymus (ICD-10: C37)b |
15 |
| Cancer in other connective tissue (ICD-10: C49)b |
<10 |
| Primary non-MM peritoneal cancer (ICD-10: C48)b |
<5 |
| Kaposis sarcoma (ICD-10: C46)b |
NA |
| Cancer in peripheral nervous system (ICD-10: C47)b |
NA |
| Secondary malignancies | |
| Lung metastases (ICD-10: C780)b |
803 |
| Metastases in mediastinum (ICD-10: C781)b |
153 |
| Pleural metastases (ICD-10: C782)b |
43 |
| Other cancers | 637 |
aIn cases where patients are diagnosed with more than one cancer, the first diagnosis is included.
bICD-10 classification codes from World Health Organizations medical classification list.